Dialysis provider DaVita (DVA +5.92%) jumps after the company raises its FY11 guidance and says...


Dialysis provider DaVita (DVA +5.92%) jumps after the company raises its FY11 guidance and says its Q3 looks solid. Q3 EPS is expected to come in between $1.43 - $1.48 per share, well above Street estimates of $1.29, while FY11 revenue should be around $1.13B - $1.16B, up from $1.08B - $1.12B, due to improved treatment volumes and decreasing operating costs.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs